The current financial score of National Health Investors Inc is 8.59. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 115.13M, representing a year-over-year increase of 28.93%, while its net profit experienced a year-over-year increase of 17.33%.
The current valuation score of National Health Investors Inc is 7.82. Its current P/E ratio is 25.70, which is 56.37% below the recent high of 40.19 and 35.73% above the recent low of 16.52.
The current earnings forecast score of National Health Investors Inc is 7.50. The average price target is 87.50, with a high of 90.00 and a low of 77.00.
The current price momentum score of National Health Investors Inc is 2.88. Currently, the stock price is trading between the resistance level at 82.79 and the support level at 75.67, making it suitable for range-bound swing trading.
The current institutional shareholding score of National Health Investors Inc is 7.00. The latest institutional shareholding proportion is 85.85%, representing a quarter-over-quarter increase of 14.86%. The largest institutional shareholder is James Simons, holding a total of 0.00 shares, representing 0.09% of shares outstanding, with 4.65% increase in holdings.
The current risk assessment score of National Health Investors Inc is 9.51. The company's beta value is 0.56. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.